Andrew Nebel active positions
| Companies | Position | Start | End |
|---|---|---|---|
Duchenne UK
 Duchenne UK Investment Trusts/Mutual FundsMiscellaneous Duchenne UK is a UK-based charity that focuses on finding effective treatments for Duchenne muscular dystrophy (DMD), a progressive condition that weakens all the muscles in the body and is diagnosed in childhood. Additionally, Duchenne connects and supports families affected by DMD. The charity funds research that aims to provide treatments for those affected by DMD and removes roadblocks that prevent patients from accessing the treatments they need. The British company was founded in 2012 by Nick Crossley, Emily Crossley, and Alex Johnson, and Emily Crossley and Alex Johnson have been the CEOs since 2012. | Chairman | - | - |
Career history of Andrew Nebel
Former positions of Andrew Nebel
| Companies | Position | Start | End |
|---|---|---|---|
Barnardo's
 Barnardo's Miscellaneous Commercial ServicesCommercial Services Barnardo's provides charitable services. The company was founded by Thomas John Barnardo in 1845 and is headquartered in Ilford, the United Kingdom. | Public Communications Contact | - | 01/07/2008 |
| Sales & Marketing | - | 01/07/2008 |
Statistics
International
| United Kingdom | 3 |
Operational
| Public Communications Contact | 1 |
| Sales & Marketing | 1 |
| Chairman | 1 |
Sectoral
| Commercial Services | 2 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Barnardo's
Barnardo's Miscellaneous Commercial ServicesCommercial Services Barnardo's provides charitable services. The company was founded by Thomas John Barnardo in 1845 and is headquartered in Ilford, the United Kingdom. | Commercial Services |
Duchenne UK
Duchenne UK Investment Trusts/Mutual FundsMiscellaneous Duchenne UK is a UK-based charity that focuses on finding effective treatments for Duchenne muscular dystrophy (DMD), a progressive condition that weakens all the muscles in the body and is diagnosed in childhood. Additionally, Duchenne connects and supports families affected by DMD. The charity funds research that aims to provide treatments for those affected by DMD and removes roadblocks that prevent patients from accessing the treatments they need. The British company was founded in 2012 by Nick Crossley, Emily Crossley, and Alex Johnson, and Emily Crossley and Alex Johnson have been the CEOs since 2012. | Miscellaneous |
- Stock Market
- Insiders
- Andrew Nebel
- Experience
